Baruch Halpert
Voorzitter bij Terragenic International Ltd.
Actieve functies van Baruch Halpert
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Terragenic International Ltd. | Voorzitter | 01-01-2018 | - |
Loopbaan van Baruch Halpert
Eerdere bekende functies van Baruch Halpert
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ENLIVEX THERAPEUTICS LTD. | Directeur/Bestuurslid | 01-01-2017 | - |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Directeur/Bestuurslid | 01-01-2017 | - |
Opleiding van Baruch Halpert
| The University of Reading | Graduate Degree |
Statistieken
Internationaal
| Israël | 3 |
| Verenigd Koninkrijk | 2 |
| Australië | 2 |
Operationeel
| Director/Board Member | 2 |
| Graduate Degree | 1 |
| Chairman | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
| Terragenic International Ltd. |
- Beurs
- Insiders
- Baruch Halpert
- Ervaring
